ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder

被引：0
|
作者：
Ryan Marino
Jeanmarie Perrone
Lewis S. Nelson
Timothy J. Wiegand
Evan S. Schwarz
Paul M. Wax
Andrew I. Stolbach
机构：
[1] Case Western Reserve University School of Medicine,Division of Emergency Medicine
[2] University of Pennsylvania,undefined
[3] Rutgers New Jersey Medical School,undefined
[4] University of Rochester Medical Center,undefined
[5] Washington University School of Medicine,undefined
[6] University of Texas Southwestern,undefined
[7] Johns Hopkins University School of Medicine,undefined
来源：
Journal of Medical Toxicology | 2019年 / 15卷
关键词：
Buprenorphine; Waiver; X-waiver; Opioid use disorder; Opioid agonist therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：307 / 309
页数：2
相关论文
共 50 条
  • [1] ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder
    Marino, Ryan
    Perrone, Jeanmarie
    Nelson, Lewis S.
    Wiegand, Timothy J.
    Schwarz, Evan S.
    Wax, Paul M.
    Stolbach, Andrew I.
    JOURNAL OF MEDICAL TOXICOLOGY, 2019, 15 (04) : 307 - 309
  • [2] ACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder
    Ryan T. Marino
    Meghan Spyres
    Timothy J. Wiegand
    Kavita M. Babu
    Andrew Stolbach
    Journal of Medical Toxicology, 2022, 18 : 71 - 73
  • [3] ACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder
    Marino, Ryan T.
    Spyres, Meghan
    Wiegand, Timothy J.
    Babu, Kavita M.
    Stolbach, Andrew
    JOURNAL OF MEDICAL TOXICOLOGY, 2022, 18 (01) : 71 - 73
  • [4] ACMT Position Statement: Caring for Patients with Opioid Use Disorder during Coronavirus Disease Pandemic
    Stolbach, Andrew
    Mazer-Amirshahi, Maryann
    Schwarz, Evan S.
    Juurlink, David
    Wiegand, Timothy J.
    Nelson, Lewis S.
    JOURNAL OF MEDICAL TOXICOLOGY, 2020, 16 (04) : 484 - 486
  • [5] ACMT Position Statement: Caring for Patients with Opioid Use Disorder during Coronavirus Disease Pandemic
    Andrew Stolbach
    Maryann Mazer-Amirshahi
    Evan S. Schwarz
    David Juurlink
    Timothy J. Wiegand
    Lewis S. Nelson
    Journal of Medical Toxicology, 2020, 16 : 484 - 486
  • [6] ACMT Position Statement: Buprenorphine Administration in the Emergency Department
    Paul M. Wax
    Andrew I. Stolbach
    Evan S. Schwarz
    Brandon J. Warrick
    Timothy J. Wiegand
    Lewis S. Nelson
    Journal of Medical Toxicology, 2019, 15 : 215 - 216
  • [7] ACMT Position Statement: Buprenorphine Administration in the Emergency Department
    Wax, Paul M.
    Stolbach, Andrew I.
    Schwarz, Evan S.
    Warrick, Brandon J.
    Wiegand, Timothy J.
    Nelson, Lewis S.
    JOURNAL OF MEDICAL TOXICOLOGY, 2019, 15 (03) : 215 - 216
  • [8] Buprenorphine prescribing at hospital discharge to patients with opioid use disorder before and after elimination of the DATA waiver
    Wang, Philip
    Bobak, Lukas
    Costa, Gabriel
    Dorney, Ian
    Mascha, Edward J.
    Barnett, Brian
    Anand, Akhil
    AMERICAN JOURNAL ON ADDICTIONS, 2024, 33 (02): : 224 - 224
  • [9] Utilization of Buprenorphine for Opioid Use Disorder After the Practitioner Waiver Removal
    Ali, Mir M.
    Chen, Jie
    Novak, Priscilla J.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2025, 68 (01) : 207 - 209
  • [10] Improving Access to Pediatric Opioid Use Disorder Treatment With Buprenorphine Waiver Training
    Bayner, Jessica
    Ignaszewski, Martha
    AMERICAN JOURNAL ON ADDICTIONS, 2021, 30 (03): : 240 - 241
12345